These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26038816)

  • 1. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
    Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
    Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
    Lee S; Kim W; Ko C; Ryu WS
    Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells.
    Choi SH; Wright JB; Gerber SA; Cole MD
    Genes Dev; 2010 Jun; 24(12):1236-41. PubMed ID: 20551172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc.
    Kalra N; Kumar V
    FEBS Lett; 2006 Jan; 580(2):431-6. PubMed ID: 16376880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
    Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
    PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 ligase SCF
    Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
    Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
    Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
    Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
    Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
    Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.
    Wang J; Li N; Huang ZB; Fu S; Yu SM; Fu YM; Zhou PC; Chen RC; Zhou RR; Huang Y; Hu XW; Fan XG
    Oncogene; 2019 Oct; 38(40):6696-6710. PubMed ID: 31391550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27(Kip1) signaling: Transcriptional and post-translational regulation.
    Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
    Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
    Chen JY; Wang MC; Hung WC
    J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.
    Huang Y; Tong S; Tai AW; Hussain M; Lok AS
    Gastroenterology; 2011 Oct; 141(4):1412-21, 1421.e1-5. PubMed ID: 21704589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.
    Kim W; Lee S; Son Y; Ko C; Ryu WS
    J Virol; 2016 Nov; 90(21):9644-9653. PubMed ID: 27535046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
    Jamal A; Husein A; Bihari C; Kumar V
    Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
    Feng Z; Yin J; Zhang Z; Chen Z; Huang L; Tang N; Wang K
    Oncogene; 2024 Apr; 43(15):1149-1159. PubMed ID: 38396292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.
    von der Lehr N; Johansson S; Wu S; Bahram F; Castell A; Cetinkaya C; Hydbring P; Weidung I; Nakayama K; Nakayama KI; Söderberg O; Kerppola TK; Larsson LG
    Mol Cell; 2003 May; 11(5):1189-200. PubMed ID: 12769844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
    Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
    Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
    Gupta P; Zhao H; Hoang B; Schwartz EL
    Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.